Mutations in the Esx-3 secretion system confer resistance to multiple chemical scaffolds in Mycobacterium tuberculosis

References

1. WHO Global tuberculosis report 2024; 2024Oct https://www.who.int/publications/i/item/9789240101531 accessed 10 February 2025
2. Gordon SV, Parish T. Microbe profile: Mycobacterium tuberculosis: Humanity’s deadly microbial foe. Microbiology 2018; 164:437–439 [View Article]
   [Google Scholar]
3. Kesicki EA, Bailey MA, Ovechkina Y, Early JV, Alling T et al. Synthesis and evaluation of the 2-aminothiazoles as anti-tubercular agents. PLoS One 2016; 11:e0155209 [View Article] [PubMed]
   [Google Scholar]
4. Bonnett SA, Dennison D, Bajpai A, Files M, Parish T. Phenylhydrazones are active against non-replicating Mycobacterium tuberculosis. bioRxiv 2018 [View Article] Preprint
   [Google Scholar]
5. Bonnett SA, Dennison D, Files M, Bajpai A, Parish T. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis. PLoS One 2018; 13:e0198059 [View Article] [PubMed]
   [Google Scholar]
6. Odingo JO, Early JV, Smith J, Johnson J, Bailey MA et al. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis. Drug Dev Res 2019; 80:566–572 [View Article] [PubMed]
   [Google Scholar]
7. Odingo J, Bailey MA, Files M, Early JV, Alling T et al. In vitro evaluation of novel nitazoxanide derivatives against Mycobacterium tuberculosis. ACS Omega 2017; 2:5873–5890 [View Article] [PubMed]
   [Google Scholar]
8. Chandrasekera NS, Alling T, Bailey MA, Files M, Early JV et al. Identification of phenoxyalkylbenzimidazoles with antitubercular activity. J Med Chem 2015; 58:7273–7285 [View Article] [PubMed]
   [Google Scholar]
9. Chandrasekera NS, Berube BJ, Shetye G, Chettiar S, O’Malley T et al. Improved phenoxyalkylbenzimidazoles with activity against Mycobacterium tuberculosis appear to target QcrB. ACS Infect Dis 2017; 3:898–916 [View Article] [PubMed]
   [Google Scholar]
10. Cleghorn LAT, Ray PC, Odingo J, Kumar A, Wescott H et al. Identification of morpholino thiophenes as novel Mycobacterium tuberculosis inhibitors, targeting QcrB. J Med Chem 2018; 61:6592–6608 [View Article] [PubMed]
    [Google Scholar]
11. Hembre E, Early JV, Odingo J, Shelton C, Anoshchenko O et al. Novel trifluoromethyl pyrimidinone compounds with activity against Mycobacterium tuberculosis. Front Chem 2021; 9:613349 [View Article] [PubMed]
    [Google Scholar]
12. Ioerger TR, O’Malley T, Liao R, Guinn KM, Hickey MJ et al. Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One 2013; 8:e75245 [View Article] [PubMed]
    [Google Scholar]
13. Sirgel FA, Wiid IJF, Helden PD. Measuring minimum inhibitory concentrations in mycobacteria. Methods Mol Biol Clifton NJ 2009; 465:173–186 [View Article]
    [Google Scholar]
14. Granados-Tristán AL, Hernández-Luna CE, González-Escalante LA, Camacho-Moll ME, Silva-Ramírez B et al. ESX-3 secretion system in Mycobacterium: an overview. Biochimie 2024; 216:46–55 [View Article] [PubMed]
    [Google Scholar]
15. Poweleit N, Czudnochowski N, Nakagawa R, Trinidad DD, Murphy KC et al. The structure of the endogenous ESX-3 secretion system. Elife 2019; 8:e52983 [View Article] [PubMed]
    [Google Scholar]
16. Granados-Tristán AL, Carrillo-Tripp M, Hernández-Luna CE, Herrera-Rodulfo A, González-Escalante LA et al. Mycobacterium susceptibility to ivermectin by inhibition of eccD3, an ESX-3 secretion system component. PLoS Comput Biol 2025; 21:e1012936 [View Article] [PubMed]
    [Google Scholar]
17. Umumararungu T, Gahamanyi N, Mukiza J, Habarurema G, Katandula J et al. Proline, a unique amino acid whose polymer, polyproline II helix, and its analogues are involved in many biological processes: a review. Amino Acids 2024; 56:50 [View Article] [PubMed]
    [Google Scholar]
18. Dragset MS, Poce G, Alfonso S, Padilla-Benavides T, Ioerger TR et al. A novel antimycobacterial compound acts as an intracellular iron chelator. Antimicrob Agents Chemother 2015; 59:2256–2264 [View Article] [PubMed]
    [Google Scholar]
19. Bhagwat A, Butts A, Greve E, Cheung Y, Melief E et al. 8-hydroxyquinoline series exerts bactericidal activity against Mycobacterium tuberculosis via copper-mediated toxicity. ACS Infect Dis 2024; 10:3692–3698 [View Article] [PubMed]
    [Google Scholar]
20. Cook GM, Hards K, Vilchèze C, Hartman T, Berney M. Energetics of respiration and oxidative phosphorylation in Mycobacteria. Microbiol Spectr 2014; 2: [View Article] [PubMed]
    [Google Scholar]
21. Bajeli S, Baid N, Kaur M, Pawar GP, Chaudhari VD et al. Terminal respiratory oxidases: a targetables vulnerability of mycobacterial bioenergetics?. Front Cell Infect Microbiol 2020; 10:589318 [View Article] [PubMed]
    [Google Scholar]